Aytu Biopharma (AYTU) Cost of Revenue (2014 - 2026)
Aytu Biopharma's Cost of Revenue was $5.7 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 16.7% from $4.88 million a year earlier and up 18.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Cost of Revenue (2014 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Cost of Revenue at Aytu Biopharma came in at $20.75 million, up 1.0% from FY2025.
- Cost of Revenue shows a five-year compound annual growth rate of -10.6% (FY2021 to FY2026).
- In earlier fiscal years, Cost of Revenue was $20.55 million in FY2025 (+27.4%), $16.13 million in FY2024 (-60.4%), $40.77 million in FY2023 (-8.2%) and $44.39 million in FY2022 (+21.8%).
- The fiscal Q4 2026 figure marks the highest quarterly Cost of Revenue since fiscal Q4 2023.
- Compared with a year earlier, Cost of Revenue was higher in six of the last eight quarters, with growth averaging 15.7%.
- The best year-over-year quarter for Cost of Revenue over five years was fiscal Q1 2022 (growth of 132.4%); the worst was fiscal Q4 2024 (a decline of 70.9%).
- Per Business Quant data, AYTU's Cost of Revenue in the three fiscal quarters before Q4 2026 was $4.81 million (Q3 2026), $5.54 million (Q2 2026) and $4.7 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | 5.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.70 Mn |
| Mar 31, 2026 | 4.81 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Dec 31, 2023 | 4.15 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 12.17 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 8.99 Mn |
| Sep 30, 2022 | 9.62 Mn |
| Jun 30, 2022 | 12.61 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 10.83 Mn |
| Sep 30, 2021 | 9.44 Mn |
API Access
Aytu Biopharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();